After a record-breaking 2021, deal activity in 2022 dropped by 37%, its largest year-over-year decline since 2001. Facing all the…
Guide to D&O Insurance for De-SPAC Transactions, 2023 Edition
While it’s true that the recent SPAC craze has significantly cooled, there are still more than 300 SPACs searching for…
Top Ten Regulatory and Litigation Risks for Private Funds in 2023
Everything, everywhere, all at once, as a descriptor, captures the litigation and regulatory risks for the asset management industry in…
Foreign direct investment reviews 2023: A global perspective
Now in its seventh year of annual publication, White & Case’s Foreign Direct Investment Reviews provides a comprehensive look into…
Securities Class Actions: Data, Trends, and Insights
The number of securities class actions filed last year fell for the fourth year in a row. But these time-consuming,…
Founders Alert: Climate Tech Funding Outlook for 2023
Despite the uncertain atmosphere with the collapse of Silicon Valley Bank and a drop in venture capital funding last year,…
Inside the Courts – An Update From Skadden Securities Litigators – March 2023
Circuits Split Over Whether Targeting Is Necessary for Seller Liability – Key Points – – While courts have long held…
Using M&A and Other Strategic Transactions to Enhance EV-Launch Readiness
In 2022 automotive original equipment manufacturers, suppliers, startups, and other participants in the electric vehicle (EV) ecosystem used mergers and…
What Is on the Minds of CFOs?
2022 was an eventful and tumultuous year that will long be remembered for aggressive Fed tightening, the Russia and Ukraine…
Silicon Valley Bank: A Timeline and Summary of Events
On Friday, March 10, the Federal Deposit Insurance Corporation (FDIC) shuttered Silicon Valley Bank (SVB) and seized its deposits in…
What is the State of Digital Health Funding in 2023?
With the pandemic, there came a digital health explosion, with companies working swiftly to bring new technologies to light that…
Navigating a Tough Market: Insights and Strategies for Emerging Public Companies Raising Capital and Avoiding Delisting
After a market flush with cash and deal flow from 2020 through the first half of 2022, in the last…
Deal Flow 3.0: European Venture Capital Deal Term Review 2022
Foreword – Despite a shift to economic headwinds, investors injected more than $95B into the European tech market in 2022,…
SEC Announces 2023 Annual Examination Priorities: Some Takeaways for Private Fund Managers
The Division of Examinations (the “Division”) of the U.S. Securities and Exchange Commission (the “SEC”) announced its 2023 examination priorities…
Navigating Uncertain Times: IPO Insights for Late-Stage Technology and Life Sciences Companies – 2023
After 2022’s challenging capital markets environment, leaders in the technology and life sciences industries have set their sights on 2023…
Missing Gold: Misappropriation by SPAC CFO Underscores Importance of Internal Controls
On February 22, 2023, the Securities and Exchange Commission (“SEC”) issued a cease-and-desist order (the “Order”) charging African Gold Acquisition…
1% Excise Tax, SPACs, and Independent Director Personal Liability: The Rock and the Hard Place
Being stuck between the choice of either disappointing investors or facing potential personal liability is the very definition of being…
SPAC Groundhog Day
On March 1, 2023, the Delaware Court of Chancery issued its third decision concerning fiduciary duties in connection with de-SPAC…
SEC Division of Examinations Releases 2023 Priorities
The Securities and Exchange Commission’s Division of Examinations (EXAMS) published its report on 2023 Examination Priorities on February 7, 2023.…
2022 Year in Review: Securities Litigation Against Life Sciences Companies
We are proud to present our seventh annual Securities Litigation Year in Review publication, in which we analyze data for…